Literature DB >> 21165437

Vascular endothelial growth factor and its type 2 receptor in hepatocellular carcinoma.

E S Gershtein1, E A Dubova, A I Shchegolev, N E Kushlinskii.   

Abstract

Histological analysis demonstrated an increase in the number of blood vessels and expression of CD34 and vascular endothelial growth factor in hepatocellular carcinoma tissue compared to adjacent liver tissue. Increased immunohistochemical expression of vascular endothelial growth factor and the content of this factor and its type 2 receptor correlated with the degree of histological differentiation and stage of the tumor.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21165437     DOI： 10.1007/s10517-010-1043-8

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  3 in total

1.  The effect of apatinib in the treatment of sorafenib resistant metastatic hepatocellular carcinoma: A case report.

Authors:  Zonghong Han; Zhongming He; Caoye Wang; Qi Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

2.  Design, synthesis, in silico docking, ADMET and anticancer evaluations of thiazolidine-2,4-diones bearing heterocyclic rings as dual VEGFR-2/EGFRT790M tyrosine kinase inhibitors.

Authors:  Nada A A M Aziz; Riham F George; Khaled El-Adl; Walaa R Mahmoud
Journal:  RSC Adv       Date:  2022-04-27       Impact factor: 4.036

3.  [Effects of cetuximab combined with celecoxib on apoptosis and KDR and AQP1 expression in lung cancer].

Authors:  Honggang Xia; Jianfei Ye; Hongyu Bai; Changli Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.